193 related articles for article (PubMed ID: 33322174)
1. Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer.
Millar EK; Browne LH; Beretov J; Lee K; Lynch J; Swarbrick A; Graham PH
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322174
[TBL] [Abstract][Full Text] [Related]
2. Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer.
Yan D; Ju X; Luo B; Guan F; He H; Yan H; Yuan J
BMC Cancer; 2022 Oct; 22(1):1082. PubMed ID: 36271354
[TBL] [Abstract][Full Text] [Related]
3. Proposal of an automated tumor-stromal ratio assessment algorithm and a nomogram for prognosis in early-stage invasive breast cancer.
Xu Q; Chen YY; Luo YH; Zheng JS; Lin ZH; Xiong B; Wang LW
Cancer Med; 2023 Jan; 12(1):131-145. PubMed ID: 35689454
[TBL] [Abstract][Full Text] [Related]
4. The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis.
Roxanis I; Colling R; Kartsonaki C; Green AR; Rakha EA
Breast Cancer Res; 2018 Feb; 20(1):11. PubMed ID: 29402299
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancer.
Vangangelt KMH; Green AR; Heemskerk IMF; Cohen D; van Pelt GW; Sobral-Leite M; Schmidt MK; Putter H; Rakha EA; Tollenaar RAEM; Mesker WE
Int J Cancer; 2020 Apr; 146(8):2296-2304. PubMed ID: 31901133
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence-based digital scores of stromal tumour-infiltrating lymphocytes and tumour-associated stroma predict disease-specific survival in triple-negative breast cancer.
Albusayli R; Graham JD; Pathmanathan N; Shaban M; Raza SEA; Minhas F; Armes JE; Rajpoot N
J Pathol; 2023 May; 260(1):32-42. PubMed ID: 36705810
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
[TBL] [Abstract][Full Text] [Related]
8. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of tumour-stroma ratio in triple-negative breast cancer.
Moorman AM; Vink R; Heijmans HJ; van der Palen J; Kouwenhoven EA
Eur J Surg Oncol; 2012 Apr; 38(4):307-13. PubMed ID: 22264965
[TBL] [Abstract][Full Text] [Related]
10. BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy.
Bouchalova K; Svoboda M; Kharaishvili G; Vrbkova J; Bouchal J; Trojanec R; Koudelakova V; Radova L; Cwiertka K; Hajduch M; Kolar Z
Tumour Biol; 2015 Jun; 36(6):4243-52. PubMed ID: 25616695
[TBL] [Abstract][Full Text] [Related]
11. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.
Matsumoto H; Thike AA; Li H; Yeong J; Koo SL; Dent RA; Tan PH; Iqbal J
Breast Cancer Res Treat; 2016 Apr; 156(2):237-47. PubMed ID: 26960711
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
[TBL] [Abstract][Full Text] [Related]
13. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumour stroma ratio in inflammatory breast cancer.
Downey CL; Thygesen HH; Sharma N; Shaaban AM
Springerplus; 2015; 4():68. PubMed ID: 25713761
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Efficacy of Tumor-Stroma Ratio in Women With Breast Cancer: A Meta-Analysis of Cohort Studies.
Jiang P; Chen Y; Liu B
Front Oncol; 2021; 11():731409. PubMed ID: 34976792
[TBL] [Abstract][Full Text] [Related]
16. New insights into the prognostic value of Ki-67 labeling index in patients with triple-negative breast cancer.
Hao S; He ZX; Yu KD; Yang WT; Shao ZM
Oncotarget; 2016 Apr; 7(17):24824-31. PubMed ID: 27050075
[TBL] [Abstract][Full Text] [Related]
17. Computerized Assessment of the Tumor-stromal Ratio and Proposal of a Novel Nomogram for Predicting Survival in Invasive Breast Cancer.
Qian X; Xiao F; Chen YY; Yuan JP; Liu XH; Wang LW; Xiong B
J Cancer; 2021; 12(12):3427-3438. PubMed ID: 33995621
[No Abstract] [Full Text] [Related]
18. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
19. TILs Immunophenotype in Breast Cancer Predicts Local Failure and Overall Survival: Analysis in a Large Radiotherapy Trial with Long-Term Follow-Up.
Millar E; Browne L; Slapetova I; Shang F; Ren Y; Bradshaw R; Ann Brauer H; O'Toole S; Beretov J; Whan R; Graham PH
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825588
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review.
Kramer CJH; Vangangelt KMH; van Pelt GW; Dekker TJA; Tollenaar RAEM; Mesker WE
Breast Cancer Res Treat; 2019 Jan; 173(1):55-64. PubMed ID: 30302588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
